Navigation Links
Cepheid to Webcast Upcoming Financial Presentations
Date:11/5/2009

SUNNYVALE, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

                 Credit Suisse Healthcare Conference, Phoenix, AZ
                 Thursday, 12 November, 2009 at 10 a.m. Mountain Time

                 NASDAQ OMX 23rd Investor Program, London, England
                 Tuesday, 1 December, 2009 at 10.45 a.m. Greenwich Mean Time

                 Piper Jaffray Health Care Conference, New York, NY
                 Wednesday, 2 December, 2009 at 1.30 p.m. Eastern Time

Accessing Webcasts

To access the live webcasts for these events, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the schedule start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the presentation and will remain available for at least 90 days.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprieta
'/>"/>

SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...EATTLE, Nov. 19 Omeros C...ted financial results for the third quarter ended ...tember 30, 2009, Omeros reported a net loss of $3....t loss of $7.4 million, or $2.54 per share, for th...eptember 30, 2009, the Company reported a net loss...
(Date:11/19/2009)...ETHESDA, Md., Nov. 19 Sp...in biotechnology for diabetes therapy, and a provi...s to food, supplement, biotechnology and pharmaceu...esday,s Annual Meeting of Shareholders. ,, At t...Nasdaq: SPEX ) elected the following members to t...
(Date:11/19/2009)... Top LASIK surgeons and recognized re...usted LASIK Surgeons made brought their fellow sur...ion correction surgery, cataract surgery, and opht...rican Academy of Ophthalmology (AAO) annual meetin...rom, Dr. Shachar Tauber, Dr. David Huang, MD, Dr. ...
(Date:11/18/2009)...VIS, Calif., Nov. 18 Marrone Bio I...opment and commercialization of effective and envi...announced that it has been named an IC20 company b... and largest national angel investing group. ,,...leading to rewarding results for all stakeholders,...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Marrone Bio Innovations Named an IC20 Company 2
...TOWN, N.J., July 29 Osteotech, Inc.,(Nasdaq: OST...lutions for,regenerative healing, announced today ...n ("FDA") has cleared its 510(k) submission for Pl...ions. In spinal applications, Plexur,M(TM) may be ...filler. In,March 2008, Osteotech received FDA clea...
...IEGO, July 29 Arena Pharmaceuticals,Inc. (Nasdaq:...rter 2008,financial results after the NASDAQ Globa...ame afternoon, Jack Lief, Arena,s President and Ch...a,s Vice President, Finance,and Chief Financial Of...stern Time (2:00 p.m. Pacific Time) to discuss the...
...DA and AMRIX Off to Strong Starts C... 2008 Earnings Guidance Despite New Spending for P...d AMRIX Investment, FRAZER, Pa., July 29 Cephalo...er 2008 sales of $485.0 million, compared,to sales... the company,s,sales guidance of $455 - $465 milli...
Other Biology Technology:Osteotech's Plexur M(TM) Biocomposite Receives FDA Clearance in Spine 2Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008 2Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008 3Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 2Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 3Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 4Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 5Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 6Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 7Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 8Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 9Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 10Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 11Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 12Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 13Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 14Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008 15
(Date:11/20/2009)...ructive pulmonary disease (COPD), a respiratory di...ysema, is the fourth leading cause of death worldw...researchers have yet to find any real treatment or... at The University of Western Ontario in London, C... new insight into the disease. , Parraga is ...
(Date:11/19/2009)...f-cutter ants, which cultivate fungus for food, ha...e to add to the list: the ant farmers, like their ...eria to make their gardens grow. The finding, repo... documents a previously unknown symbiosis between ...af-cutter ants have come to dominate the American ...
(Date:11/19/2009)... survey of genetic diversity in maize, also known ...e developed a gene map that should pave the way to...or source of food, fuel, animal feed and fiber aro...gene map known as a haplotype map, charts genetic ...7 inbred lines of maize. The research team, led by...
Breaking Biology News(10 mins):Gaining a better picture of lung disease 2Like humans, ants use bacteria to make their gardens grow 2Cantel Medical Corp To Present at the CL King 7th Annual Best Ideas Conference 56121 1ValGenesis Inc the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies Today Announced Support for E 13821 1ValGenesis Inc the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies Today Announced Support for E 13821 2Echo Therapeutics to Present at Rodman 26 Renshaw 2009 Annual Global Investment Conference 56117 1Echo Therapeutics to Present at Rodman 26 Renshaw 2009 Annual Global Investment Conference 56117 2
...ribute as much as vehicles to carbon emissions in ...able. New research published in the online open ac...ies these emissions and suggests fires will compli... Christine Wiedinmyer of the National Center for ...ity of Colorado, both in Boulder, US, used satelli...
...gas-thirsty cars and pollution-belching factories ... Circling the northern hemisphere, the conifer-dom...ems on earth - act as a vast natural regulator of ... the University of Wisconsin-Madison are studying ... climate influence carbon levels in this forest sy...
...vember 15th issues of Biophysical Journal, publish...nline. Topics of interest include voltage-gated p...rug design, the absence of large lipid rafts in ce...er. , Volume 93, Issue 9, November 1, 2007 , ... a Membrane Environment , Vishwanath Jogini, Unive...
Other Biology News:US faces burning emissions issue 2Wildfire drives carbon levels in northern forests 2Media highlights in the November issues of Biophysical Journal 2Media highlights in the November issues of Biophysical Journal 3
Mouse Anti-Human Gastric Carcinoma Marker [BY-1] Monoclonal Antibody, Unconjugated, Clone 3H11 from Santa Cruz Biotechnology, Inc.
Goat Anti-LTBP-1 (E-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Human Dectin-1 / CLECSF12 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Rat Anti-Mouse VEGF R1 / Flt-1 Monoclonal Antibody, Allophycocyanin Conjugated, Clone 141522 from R&D Systems
Biology Products: